Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Helicobacter pylori infection with intestinal metaplasia: An independent risk factor for colorectal adenomas.

Yan Y, Chen YN, Zhao Q, Chen C, Lin CJ, Jin Y, Pan S, Wu JS.

World J Gastroenterol. 2017 Feb 28;23(8):1443-1449. doi: 10.3748/wjg.v23.i8.1443.

2.

Lung, gastric and colorectal cancer mortality by occupation and industry among working-aged men in Japan.

Eguchi H, Wada K, Prieto-Merino D, Smith DR.

Sci Rep. 2017 Feb 23;7:43204. doi: 10.1038/srep43204.

3.

The challenge of preserving cardiorespiratory fitness in physically inactive patients with colon or breast cancer during adjuvant chemotherapy: a randomised feasibility study.

Møller T, Lillelund C, Andersen C, Bloomquist K, Christensen KB, Ejlertsen B, Nørgaard L, Wiedenbein L, Oturai P, Breitenstein U, Adamsen L.

BMJ Open Sport Exerc Med. 2015 Oct 23;1(1):e000021. eCollection 2015.

4.

Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.

Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S.

World J Gastroenterol. 2016 May 14;22(18):4594-603. doi: 10.3748/wjg.v22.i18.4594. Review.

5.

Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker.

Beckett EL, Martin C, Choi JH, King K, Niblett S, Boyd L, Duesing K, Yates Z, Veysey M, Lucock M.

BBA Clin. 2015 Jul 7;4:45-51. doi: 10.1016/j.bbacli.2015.06.006. eCollection 2015 Dec.

6.

Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Hanyuda A, Kim SA, Martinez-Fernandez A, Qian ZR, Yamauchi M, Nishihara R, Morikawa T, Liao X, Inamura K, Mima K, Cao Y, Zhang X, Wu K, Chan AT, Giovannucci EL, Meyerhardt JA, Fuchs CS, Shivdasani RA, Ogino S.

Ann Surg Oncol. 2016 Mar;23(3):908-17. doi: 10.1245/s10434-015-4967-4. Epub 2015 Nov 17.

7.

Index-based dietary patterns and colorectal cancer risk: a systematic review.

Steck SE, Guinter M, Zheng J, Thomson CA.

Adv Nutr. 2015 Nov 13;6(6):763-73. doi: 10.3945/an.115.009746. Print 2015 Nov. Review.

8.

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.

García-Alfonso P, Ferrer A, Gil S, Dueñas R, Pérez MT, Molina R, Capdevila J, Safont MJ, Castañón C, Cano JM, Lara R.

Target Oncol. 2015 Dec;10(4):453-65. doi: 10.1007/s11523-015-0362-0. Epub 2015 Mar 11. Review.

9.

MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells.

Mo JS, Alam KJ, Kang IH, Park WC, Seo GS, Choi SC, Kim HS, Moon HB, Yun KJ, Chae SC.

Oncotarget. 2015 Feb 20;6(5):2843-55.

10.

Diet and lifestyle in survivors of colorectal cancer.

Lee J, Jeon JY, Meyerhardt JA.

Hematol Oncol Clin North Am. 2015 Feb;29(1):1-27. doi: 10.1016/j.hoc.2014.09.005. Review.

11.

Acute onset and rapid progression of multiple organ failure in a young adult with undiagnosed disseminated colonic adenocarcinoma.

Frestad D, Perner A, Pedersen UG.

BMJ Case Rep. 2014 Sep 24;2014. pii: bcr2014205002. doi: 10.1136/bcr-2014-205002.

12.
13.

The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients.

Liu C, Huang Z, Jiang H, Shi F.

Biomed Res Int. 2014;2014:871263. doi: 10.1155/2014/871263. Epub 2014 Jul 1.

14.

Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country.

Zahir MN, Azhar EM, Rafiq S, Ghias K, Shabbir-Moosajee M.

ISRN Oncol. 2014 Apr 1;2014:461570. doi: 10.1155/2014/461570. eCollection 2014.

15.

Rare multiple primary malignancies among surgical patients-a single surgical unit experience.

Carlomagno N, Santangelo ML, Mastromarino R, Calogero A, Dodaro C, Renda A.

Ecancermedicalscience. 2014 Jun 18;8:438. doi: 10.3332/ecancer.2014.438. eCollection 2014.

16.

Colorectal cancer: from prevention to personalized medicine.

Binefa G, Rodríguez-Moranta F, Teule A, Medina-Hayas M.

World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786. Review.

17.

Percent Body Fat Measured by Bioelectrical Impedance is Not Associated with Colorectal Adenoma Status.

Frantz DJ, Crockett SD, Galanko JA, Sandler RS.

J Gastroenterol Hepatol Res. 2013;2(3):445-448.

18.
19.

At cancer diagnosis: a 'window of opportunity' for behavioural change towards physical activity. A randomised feasibility study in patients with colon and breast cancer.

Møller T, Lillelund C, Andersen C, Ejlertsen B, Nørgaard L, Christensen KB, Vadstrup E, Diderichsen F, Hendriksen C, Bloomquist K, Adamsen L.

BMJ Open. 2013 Nov 4;3(11):e003556. doi: 10.1136/bmjopen-2013-003556.

20.

Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ.

Am J Epidemiol. 2013 Aug 1;178(3):339-49. doi: 10.1093/aje/kws580. Epub 2013 Jul 3.

Supplemental Content

Support Center